Charvin, Delphine,Manteau, Baptiste,Pomel, Vincent,Conquet, François
申请号：
NZ72885315
公开号：
NZ728853A
申请日:
2015.08.27
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
The present invention provides a novel chromone oxime derivative of formula (I), which is a modulator of nervous system receptors sensitive to glutamate and, furthermore, presents an advantageously high brain penetration upon oral administration. The invention also relates to a pharmaceutical composition containing this compound, and to its use for the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions, or conditions which can be affected by alteration of glutamate level or signalling, particularly acute and chronic neurological and/or psychiatric disorders.
